Title: FXTAS, SCA10, and SCA17 in American patients with movement disorders
Abstract: American Journal of Medical Genetics Part AVolume 136A, Issue 1 p. 87-89 Research Letter FXTAS, SCA10, and SCA17 in American patients with movement disorders Ana I. Seixas, Ana I. Seixas Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland UnIGENe, Institute for Molecular and Cellular Biology, University of Porto, Porto, PortugalSearch for more papers by this authorMartin H. Maurer, Martin H. Maurer Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Physiology and Pathophysiology, University of Heidelberg, Heidelberg, GermanySearch for more papers by this authorMark Lin, Mark Lin Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this authorColleen Callahan, Colleen Callahan Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this authorAlka Ahuja, Alka Ahuja Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this authorTohru Matsuura, Tohru Matsuura Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TexasSearch for more papers by this authorChristopher A. Ross, Christopher A. Ross Departments of Psychiatry (Division of Neurobiology), Neurology and Neuroscience, and Program in Cellular and Molecular Medicine Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this authorFuki M. Hisama, Fuki M. Hisama Department of Neurology, Yale University School of Medicine, New Haven, ConnecticutSearch for more papers by this authorIsabel Silveira, Isabel Silveira UnIGENe, Institute for Molecular and Cellular Biology, University of Porto, Porto, PortugalSearch for more papers by this authorRussell L. Margolis, Corresponding Author Russell L. Margolis [email protected] Departments of Psychiatry (Division of Neurobiology) and Neurology, and Program in Cellular and Molecular Medicine Johns Hopkins University School of Medicine, Baltimore, MarylandMeyer 2-181, 600 N Wolfe Street, Baltimore, MD 21287.Search for more papers by this author Ana I. Seixas, Ana I. Seixas Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland UnIGENe, Institute for Molecular and Cellular Biology, University of Porto, Porto, PortugalSearch for more papers by this authorMartin H. Maurer, Martin H. Maurer Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland Department of Physiology and Pathophysiology, University of Heidelberg, Heidelberg, GermanySearch for more papers by this authorMark Lin, Mark Lin Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this authorColleen Callahan, Colleen Callahan Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this authorAlka Ahuja, Alka Ahuja Division of Neurobiology, Department of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this authorTohru Matsuura, Tohru Matsuura Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TexasSearch for more papers by this authorChristopher A. Ross, Christopher A. Ross Departments of Psychiatry (Division of Neurobiology), Neurology and Neuroscience, and Program in Cellular and Molecular Medicine Johns Hopkins University School of Medicine, Baltimore, MarylandSearch for more papers by this authorFuki M. Hisama, Fuki M. Hisama Department of Neurology, Yale University School of Medicine, New Haven, ConnecticutSearch for more papers by this authorIsabel Silveira, Isabel Silveira UnIGENe, Institute for Molecular and Cellular Biology, University of Porto, Porto, PortugalSearch for more papers by this authorRussell L. Margolis, Corresponding Author Russell L. Margolis [email protected] Departments of Psychiatry (Division of Neurobiology) and Neurology, and Program in Cellular and Molecular Medicine Johns Hopkins University School of Medicine, Baltimore, MarylandMeyer 2-181, 600 N Wolfe Street, Baltimore, MD 21287.Search for more papers by this author First published: 11 May 2005 https://doi.org/10.1002/ajmg.a.30761Citations: 29Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL REFERENCES Brown WT, Houck GE Jr., Jeziorowska A, Levinson FN, Ding X, Dobkin C, Zhong N, Henderson J, Brooks SS, Jenkins EC. 1993. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA 270: 1569– 1575. Brussino A, Gellera C, Saluto A, Mariotti C, Arduino C, Castellotti B, Camerlingo M, de Angelis V, Orsi L, Tosca P, Migone N, Taroni F, Brusco A. 2005. FMR1 gene premutation is a frequent genetic cause of late-onset sporadic cerebellar ataxia. Neurology 64: 145– 147. Cagnoli C, Michielotto C, Matsuura T, Ashizawa T, Margolis RL, Holmes SE, Gellera C, Migone N, Brusco A. 2004. Detection of large pathogenic expansions in FRDA1, SCA10, and SCA12 genes using a simple fluorescent repeat-primed PCR assay. J Mol Diagn 6: 96– 100. Dombrowski C, Levesque S, Morel ML, Rouillard P, Morgan K, Rousseau F. 2002. Premutation and intermediate-size FMR1 alleles in 10572 males from the general population: loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet 11: 371– 378. Fahn S, Elton RL, UPDRS Development Committee. 1987. The Unified Parkinson's Disease Rating Scale. In: S Fahn, CD Marsden, DB Calne, M Goldstein, editors. Recent developments in Parkinson's disease. Florham Park: Macmillam Healthcare Information. p 153– 163, 293–304. Garcia Arocena D, Breece KE, Hagerman PJ. 2003. Distribution of CGG repeat sizes within the fragile X mental retardation 1 (FMR1) homologue in a non-human primate population. Hum Genet 113: 371– 376. Hagerman RJ, Hagerman PJ. 2002. The fragile X premutation: into the phenotypic fold. Curr Opin Genet Dev 12: 278– 283. Hagerman RJ, Leehey M, Heinrichs W, Tassone F, Wilson R, Hills J, Grigsby J, Gage B, Hagerman PJ. 2001. Intention tremor, parkinsonism, and generalized brain atrophy in male carriers of fragile X. Neurology 57: 127– 130. Hagerman RJ, Leavitt BR, Farzin F, Jacquemont S, Greco CM, Brunberg JA, Tassone F, Hessl D, Harris SW, Zhang L, Jardini T, Gane LW, Ferranti J, Ruiz L, Leehey MA, Grigsby J, Hagerman PJ. 2004. Fragile-X-associated tremor/ataxia syndrome (FXTAS) in females with the FMR1 premutation. Am J Hum Genet 74: 1051– 1056. Jacquemont S, Hagerman RJ, Leehey MA, Hall DA, Levine RA, Brunberg JA, Zhang L, Jardini T, Gane LW, Harris SW, Herman K, Grigsby J, Greco CM, Berry-Kravis E, Tassone F, Hagerman PJ. 2004. Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population. JAMA 291: 460– 469. Koide R, Kobayashi S, Shimohata T, Ikeuchi T, Maruyama M, Saito M, Yamada M, Takahashi H, Tsuji S. 1999. A neurological disease caused by an expanded CAG trinucleotide repeat in the TATA-binding protein gene: a new polyglutamine disease? Hum Mol Genet 8: 2047– 2053. Macpherson J, Waghorn A, Hammans S, Jacobs P. 2003. Observation of an excess of fragile-X premutations in a population of males referred with spinocerebellar ataxia. Hum Genet 112: 619– 620. Margolis RL. 2002. The spinocerebellar ataxias: order emerges from chaos. Curr Neurol Neurosci Rep 2: 447– 456. Matsuura T, Yamagata T, Burgess DL, Rasmussen A, Grewal RP, Watase K, Khajavi M, McCall AE, Davis CF, Zu L, Achari M, Pulst SM, Alonso E, Noebels JL, Nelson DL, Zoghbi HY, Ashizawa T. 2000. Large expansion of the ATTCT pentanucleotide repeat in spinocerebellar ataxia type 10. Nat Genet 26: 191– 194. Milunsky JM, Maher TA. 2004. Fragile X carrier screening and spinocerebellar ataxia in older males. Am J Med Genet 125A: 320. Nakamura K, Jeong SY, Uchihara T, Anno M, Nagashima K, Nagashima T, Ikeda S, Tsuji S, Kanazawa I. 2001. SCA17, a novel autosomal dominant cerebellar ataxia caused by an expanded polyglutamine in TATA-binding protein. Hum Mol Genet 10: 1441– 1448. Rasmussen A, Matsuura T, Ruano L, Yescas P, Ochoa A, Ashizawa T, Alonso E. 2001. Clinical and genetic analysis of four Mexican families with spinocerebellar ataxia type 10. Ann Neurol 50: 234– 239. Schols L, Bauer P, Schmidt T, Schulte T, Riess O. 2004. Autosomal dominant cerebellar ataxias: clinical features, genetics, and pathogenesis. Lancet Neurol 3: 291– 304. Tan EK, Zhao Y, Puong KY, Law HY, Chan LL, Yew K, Tan C, Shen H, Chandran VR, Teoh ML, Yih Y, Pavanni R, Wong MC, Ng IS. 2004. Fragile X premutation alleles in SCA, ET, and parkinsonism in an Asian cohort. Neurology 63: 362– 363. Teive HA, Roa BB, Raskin S, Fang P, Arruda WO, Neto YC, Gao R, Werneck LC, Ashizawa T. 2004. Clinical phenotype of Brazilian families with spinocerebellar ataxia 10. Neurology 63: 1509– 1512. Trouillas P, Takayanagi T, Hallett M, Currier RD, Subramony SH, Wessel K, Bryer A, Diener HC, Massaquoi S, Gomez CM, Coutinho P, Ben Hamida M, Campanella G, Filla A, Schut L, Timann D, Honnorat J, Nighoghossian N, Manyam B. 1997. International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome. The Ataxia Neuropharmacology Committee of the World Federation of Neurology. J Neurol Sci 145: 205– 211. Van Esch H, Dom R, Bex D, Salden I, Caeckebeke J, Wibail A, Borghgraef M, Legius E, Fryns JP, Matthijs G. 2005. Screening for FMR-1 premutations in 122 older Flemish males presenting with ataxia. Eur J Hum Genet 13: 121– 123. Zuhlke C, Budnik A, Gehlken U, Dalski A, Purmann S, Naumann M, Schmidt M, Burk K, Schwinger E. 2004. FMR1 premutation as a rare cause of late onset ataxiaEvidence for FXTAS in female carriers. J Neurol 251: 1418– 1419. Citing Literature Volume136A, Issue11 July 2005Pages 87-89 ReferencesRelatedInformation
Publication Year: 2005
Publication Date: 2005-05-11
Language: en
Type: letter
Indexed In: ['crossref', 'pubmed']
Access and Citation
Cited By Count: 37
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot